TCF7L2 and colon adenocarcinoma: Furthermore, survival analyses based on gene expression (TCGA & GTEx profile) and mutational status (TCGA COAD & Pan‐cancer datasets) for colon adenocarcinoma identified CDKN2A, INHBA increased expression, and CDKN2A and TCF7L2 mutations as predictors of bad prognosis in metastatic patients (Table 1).